Paroxysmal Adipose Hyperplasia (PAH) Fundamentals Explained
A multicenter evaluation of all individuals who underwent CS treatment between January 2015 and December 2019 at 8 Canadian healthcare centers was carried out. Data abstracted included signs, management strategy, consequence, operator features, system qualities, patient properties, overall body region, and CS treatment specifics. Incidence of PAH w